Is LSA (Morning Glory) legal in France?

Legal status

LSA is classified as a narcotic in France. The consolidated order of 22 February 1990 fixing the list of substances classified as narcotics carries the entry « amide de l’acide lysergique », and that printed entry is the operative text rather than any chemical resemblance to it. The entry is a single designation, amide de l’acide lysergique, with nothing bracketed and no alternative spelling offered beside it. The name LSA is not itself the printed entry; the list reaches it through amide de l’acide lysergique. The order's express clauses carry the entry across the salts, stereoisomers and preparations it names, and those textual bridges were applied while family resemblance without an applicable clause was not. France works from closed enumerated lists given effect by the Code de la santé publique, so the position for LSA rests on the list reaching it and not on the substance belonging to a group the list is silent about. The consolidated Légifrance version carries the amendment history and later amending orders are folded into it, so this placement is the one standing on 18 September 2026.

Consequences if caught

Capital exposure: none. France abolished the death penalty and no French drug provision carries one. The ceiling that does run on this row is life imprisonment under Penal Code article 222-34, which reaches the person who directs or organises a group whose object is illicit narcotics activity, and it is available because the consolidated order of 22 February 1990 carries LSA among the narcotics at the entry « amide de l’acide lysergique ». The entry is a single designation with nothing bracketed beside it, and LSA is not itself that entry, the order reaching this row through amide de l’acide lysergique. The order's express clauses carry the entry across the salts, stereoisomers and preparations it names, and those textual bridges were applied while family resemblance without an applicable clause was not. Conduct short of that is charged elsewhere: article L. 3421-1 of the Code de la santé publique addresses illicit use and stands apart from organised trafficking. The dossier settles the ceiling and the article carrying it without printing the intermediate trafficking tariffs, so no figure between personal use and article 222-34 is stated here.

If prescribed or medical

The country level rule in France is that a Schengen traveller certificate or a medicines carriage list is evidential and administrative, not the criminal schedule, so producing one changes what a traveller can show and not where a substance sits. Attached to this substance: LSA is on the narcotics side of the 22 February 1990 pair of orders at the entry « amide de l’acide lysergique », which means the certificate can evidence a lawful medical carriage while the narcotics classification continues to govern the conduct. The dossier records no per substance prescribing route for LSA and none is invented here.

Documentation

Carry the Schengen traveller certificate together with the prescription and the original dispensing packaging for LSA, and treat the certificate as proof of lawful carriage rather than as anything that alters the schedule. Provenance: the placement relied on is the entry « amide de l’acide lysergique » in the Arrêté du 22 février 1990 fixant la liste des substances classées comme stupéfiants, read on Légifrance at https://www.legifrance.gouv.fr/loda/id/JORFTEXT000000533085 and checked on 18 September 2026. Both consolidated orders were followed through their terminal annex material and their amendment links, so what is quoted is the consolidated entry and not the 1990 original wording.

Drug laws and enforcement change and vary within a country. This is not legal advice. Always confirm with France’s embassy or official drug authority before traveling; penalties can be severe, including imprisonment.